Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00864227 · ClinicalTrials.gov registry record · Phase 2

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

A Phase 2 study, sponsored by Medical College of Wisconsin.

Completed
Registry status
Phase 2
Development phase
54
Enrollment target

NCT00864227 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00864227, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
Phase 2
Development phase
54 participants
Enrollment target

Study Summary

A bone marrow transplant, which is a type of stem cell transplant, is a treatment option for people with leukemia or lymphoma. Recently, stem cell transplants using umbilical cord blood have become a treatment option for people with these types of cancers. This study will evaluate the effectiveness of a stem cell transplant using umbilical cord blood, along with lower doses of chemotherapy, to treat people with leukemia or lymphoma.

Interventions

  • BIOLOGICAL GVHD prophylaxis
  • BIOLOGICAL Hematopoietic Umbilical Cord Blood Stem Cell Transplantation

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2008-12
Est. Completion 2013-11
Phase Phase 2

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT00864227

The ClinicalTrials.gov registry entry for NCT00864227 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which GVHD prophylaxis is the first listed.

NCT00864227 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00864227 about?

NCT00864227 is a clinical study titled "Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)". A bone marrow transplant, which is a type of stem cell transplant, is a treatment option for people with leukemia or lymphoma. Recently, stem cell transplants using umbilical cord blood have become a treatment option for people with these types of cancers. This study will evaluate the effectiveness ...

What is the current status of trial NCT00864227?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2008-12. Estimated completion is 2013-11.

What interventions are being tested in trial NCT00864227?

The interventions under investigation include: GVHD prophylaxis (BIOLOGICAL), Hematopoietic Umbilical Cord Blood Stem Cell Transplantation (BIOLOGICAL).

Who is sponsoring clinical trial NCT00864227?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.